Chris Sale Just Shared The Mindset Behind His Braves Revival

Chris Sale's journey from injury setbacks to an award-winning pitcher with the Braves highlights a remarkable career revival in his late 30s.

Chris Sale’s path back to the top has been a long one, and the Braves left-hander says the turnaround really began before he ever put on an Atlanta uniform.

Sale, who has reestablished himself as one of the game’s premier pitchers, spoke with FOX Sports ahead of Tuesday night’s MLB All-Star Game and laid out how he got back to elite form after years of injuries and uneven results. The 37-year-old is now in the middle of another strong season, carrying a 2.20 ERA across 17 outings in 2026.

For Sale, the reset started in the offseason of '23.

“I think it started in the offseason of '23,” Sale said. “Because '23 I get hurt, I miss a couple months… When I came back, my stuff wasn't good.

It didn't have that, like, life to it. But I pitched well… I just remember, I told myself going into that offseason, I was like, ‘I have one more year left in Boston', I told my wife, I told all the guys, I was like, ‘I'm going for it.

I'm not gonna miss a single day of throwing, I'm not missing a single workout'… I just felt like I owed it to Boston, I need to give them everything I have because I really felt guilty for those years of not being able to show up and not play… And then about halfway through all that I get traded.”

That work paid off quickly once he arrived in Atlanta. The Braves got the version of Sale they were hoping for after acquiring him from the Boston Red Sox before the 2024 season, and he responded by winning the National League Cy Young Award.

Now, with his career back on track and his numbers still sparkling, Sale is showing no signs of slowing down.

In Other News...

Braves Get An Acuna Rehab Check And A Surprise Farm System Jolt

Ronald Acuna Jr. took another step in his rehab work with the FCL Braves on Monday, appearing for the second time as he continues to work back from a hamstring strain. The box score offered the kind of early-summer checkpoint Atlanta is watching closely: Acuna was in the lineup against the FCL Twins, while Ha-Seong Kim and Ray Kerr also got into the game as the organization keeps cycling big-league talent through the complex league level.

Elsewhere in the system, the Braves got an unexpected jolt from the DSL. Cesar Navarro delivered a complete-game shutout against the DSL Giants Orange, a type of performance that barely shows up in that league and has been scarce for Atlanta's affiliate in recent years. For a farm system that is usually tracked most closely for rehab updates and prospect development, it was the kind of pitching line that tends to travel quickly through the organization. [Read more 🡒]

Chris Sales All-Star Benching Says Everything About These Braves

Chris Sale made the All-Star team as one of the Braves most important arms, but he never took the mound in the game, a reminder of how carefully Atlanta is managing every meaningful start it can get from him. With the rotation battered by injuries, regression and inconsistency, the Braves are treating Sale less like an exhibition piece and more like a needed answer in a season that still has real stakes attached to every decision.

The urgency is easy to see with Atlantas NL East cushion trimmed to two games, which makes preserving Sale for the stretch run feel less like caution and more like necessity. The club has already lined him up to start its first game after the break against the Rangers, and that assignment says plenty about where the Braves believe their margin for error really is. [Read more 🡒]

Braves Are Being Tied To A Deadline Arm Fans Should Fear

The Braves are expected to shop for starting pitching ahead of the trade deadline, and one name that has surfaced is a familiar one for fans who have followed the market closely. The appeal is obvious on paper: Atlanta needs help in the rotation, and a veteran arm with a track record of success would fit the kind of midseason upgrade the club usually explores when it believes a run is there to be made.

There is plenty of reason for caution, though, because the pitcher in question has not looked like the same force he was a year ago. His strikeout rate has slipped, his fastball has lost nearly two mph, and he has had more trouble missing bats and limiting hard contact, which makes any deal feel far less straightforward than the name recognition suggests. For Atlanta, the question is whether the price in money and prospect capital would be worth the gamble, especially if the front office decides this is the kind of move it can only make under very specific conditions. [Read more 🡒]